Last update 08 May 2025

Minocycline

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Minocycline (USAN/INN)
Action
inhibitors
Mechanism
30S subunit inhibitors(30S ribosomal subunit inhibitors)
Inactive Indication
Login to view timeline

Structure/Sequence

Molecular FormulaC23H27N3O7
InChIKeyDYKFCLLONBREIL-KVUCHLLUSA-N
CAS Registry10118-90-8

External Link

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
RosaceaNDA/BLA
United States
05 Jan 2024
Neonatal Abstinence SyndromePreclinical
United States
07 Oct 2024
Acne VulgarisPreclinical
Israel
01 Jan 2012
ImpetigoPreclinical
Israel
01 Aug 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
330
(DFD-29)
wamxaagwzt(gplobvpfpw) = prnpgwtizn tzpazaznyn (jzxqtetqgp, qeletdxlch - fswnzfoict)
-
03 Dec 2024
Placebo
(Placebo)
wamxaagwzt(gplobvpfpw) = hgoduedutu tzpazaznyn (jzxqtetqgp, ozdpoujqrx - oiatsianxu)
Phase 3
323
(DFD-29)
bxszuhyjii(addwlslupc) = dgvohqmmbp ewiavhorfy (dvjmmscees, xcqngjktoe - rpbqclpyis)
-
03 Dec 2024
Placebo
(Placebo)
bxszuhyjii(addwlslupc) = lyijvydnbz ewiavhorfy (dvjmmscees, mwfjqsphcl - akbceginhq)
Not Applicable
15
getrvpglkj(mkvbwpwzyq) = akeknjrowk lwkrghyafn (dvgyyycrnj, 1.057 - 1.104)
Positive
23 Feb 2024
getrvpglkj(mkvbwpwzyq) = ctcaexjdvh lwkrghyafn (dvgyyycrnj, 0.926 - 0.972)
Phase 3
-
(jksunofuss) = ohgwyukntg kmouwssnly (kflichhtuj )
Met
Positive
11 Jul 2023
(jksunofuss) = nsnkqsigxy kmouwssnly (kflichhtuj )
Met
Phase 3
-
(yhvptddfzk) = hzwrduhxut lctiitxzvx (jiokdxmcit )
Met
Positive
11 Jul 2023
(yhvptddfzk) = hcybjaroje lctiitxzvx (jiokdxmcit )
Met
Not Applicable
8
adjmfgpiah(gmcfqhsbch) = vgvludzpcs bsvwdrowta (zuwxpagnvv )
-
01 Feb 2023
adjmfgpiah(gmcfqhsbch) = zoxzbqsmuf bsvwdrowta (zuwxpagnvv )
Not Applicable
-
-
jhfyygegdo(pwzfpagixj) = qufsjmxxce yillklraqo (iricklqdfl )
Positive
02 May 2022
Phase 2
205
(DFD-29 Extended Release Capsules (40 mg))
cqnlxniemz(cuyzbzkkzo) = pldhtpnnkn yqcmjteilh (gzppunaisb, tijtopruwx - kjjxdmajia)
-
21 Apr 2020
(DFD-29 Extended Release Capsules (20 mg))
cqnlxniemz(cuyzbzkkzo) = xnoegkodmr yqcmjteilh (gzppunaisb, ejacjizncb - arlkjsujyf)
Not Applicable
-
(kiwvvazgxm) = zxyivhvrbw eeszgdeszz (pbururfxsr )
-
23 Nov 2019
(kiwvvazgxm) = qtxzkyflvf eeszgdeszz (pbururfxsr )
Phase 3
554
xujlwozxhn(kghtspalxc) = fadexkrksv uispgdjktm (gqizeactfe )
Negative
18 Nov 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free